StockWatch
·
Pharmaceuticals
Quarterly Result14 May 2026, 06:01 pm

Sanjivani Paranteral Approves Audited Financial Results for FY26

AI Summary

Sanjivani Paranteral Ltd. announced the approval of audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026, during its board meeting held on May 14, 2026. The meeting, which commenced at 04:00 P.M. and concluded at 05:30 P.M., included a review of the audit report. R. B. Gohil & Co., Chartered Accountants, conducted the audit and issued an independent auditor's report, stating that the financial results present a true and fair view in accordance with regulatory requirements and accounting standards.

Key Highlights

  • Sanjivani Paranteral approved audited financial results for FY26.
  • The board meeting was held on May 14, 2026.
  • R. B. Gohil & Co. issued an independent auditor's report.
  • The audit report states a true and fair view of financial results.
  • Results are compliant with SEBI Listing Regulations.